I think we are just being shown a glimpse of how powerful the platform really is.
Looking like an embarrassment of riches in choice of lead candidate, choice of application and drug cargo.
Thankfully they are also working hard on explaining what each slide actually means - this will go a long way in helping the investors that the CEO is presenting to can actually understand what they are being shown. I asked a lot of questions about what the charts and colours actually mean when I was over there so I suspect they have realised they need to really explain it in basic terms so we know what they are talking about.
We seem to have gone from from one lead candidate to 'a fleet' and we are now confident of a model for 'near term commercial value' which will be validated in the next 6-7 months.
Getting to the pointy end now and if it's successful then I wonder if we make it to 2019 . . . .
- Forums
- ASX - By Stock
- Ann: New Delivery Vehicles Show Improved Performance Inside Cells
PYC
pyc therapeutics limited
Add to My Watchlist
3.63%
!
$1.29

I think we are just being shown a glimpse of how powerful the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M |
Open | High | Low | Value | Volume |
$1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 58344 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.285 |
1 | 790 | 1.240 |
1 | 300 | 1.230 |
1 | 20000 | 1.220 |
1 | 4000 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.280 | 4000 | 1 |
1.285 | 58344 | 1 |
1.290 | 24500 | 1 |
1.300 | 8000 | 1 |
1.325 | 9001 | 1 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online